Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C16H26O2 |
| Molecular Weight | 250.3764 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 4 / 4 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
C[C@@]12CC[C@H]3C(C)(C)CCC[C@]3(C)[C@H]1CC(=O)O2
InChI
InChIKey=IMKJGXCIJJXALX-SHUKQUCYSA-N
InChI=1S/C16H26O2/c1-14(2)7-5-8-15(3)11(14)6-9-16(4)12(15)10-13(17)18-16/h11-12H,5-10H2,1-4H3/t11-,12+,15-,16+/m0/s1
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/17416571Curator's Comment: description was created based on several sources, including
US Patent Application No. 2010/0183527 A1
Sources: https://www.ncbi.nlm.nih.gov/pubmed/17416571
Curator's Comment: description was created based on several sources, including
US Patent Application No. 2010/0183527 A1
Sclareolide is a sesquiterpene lactone natural product derived from various plant sources including Salvia sclarea, Salvia yosgadensis, and cigar tobacco. Sclareolide demonstrated good antibacterial activity against common human pathogens, including Staphylococcus aureus, Pseudomonas aeruginosa, Escherichia coli and Enterococcus faecalis. Sclareolide is not generally known for its bioactive properties. Instead, it is mostly used as a fixative or base in the perfume industry. It is also used in cosmetics, because it is thought to contribute to tanning of skin and/or darkening of hair.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Manganese porphyrins catalyze selective C-H bond halogenations. | 2010-09-22 |
|
| Synthesis and biological evaluation of (+)-labdadienedial, derivatives and precursors from (+)-sclareolide. | 2010-09 |
|
| Enantiospecific, biosynthetically inspired formal total synthesis of (+)-liphagal. | 2010-05-21 |
|
| Identification and analysis of in planta expressed genes of Magnaporthe oryzae. | 2010-02-10 |
|
| Differential enhancement of leukaemia cell differentiation without elevation of intracellular calcium by plant-derived sesquiterpene lactone compounds. | 2008-11 |
|
| Structure revision and synthesis of a novel labdane diterpenoid from Zingiber ottensii. | 2008-08-21 |
|
| (3aS,7S,9aS,9bR)-3a,6,6,9a-Tetra-methyl-2-oxoperhydro-naphtho[2,1-b]furan-7-yl acetate. | 2008-08-16 |
|
| Antibacterial and cytotoxic activity of the acetone extract of the flowers of Salvia sclarea and some natural products. | 2007-04 |
|
| Novel microbial transformations of sclareolide. | 2007-01 |
|
| The nicholas approach to natural product hybrids. | 2006-08-16 |
|
| Synthesis and biological activity of (+)-hedychilactone A and its analogs from (+)-sclareolide. | 2006-03-15 |
|
| Synthesis of alpha-onoceradiene-like terpene dimers by intermolecular metathesis processes. | 2006-02-16 |
|
| Diversity oriented synthesis of hispanane-like terpene derivatives from (R)-(+)-sclareolide. | 2005-06-06 |
|
| Synthesis of pelorol and analogues: activators of the inositol 5-phosphatase SHIP. | 2005-03-17 |
|
| Photochemical access to tetra- and pentacyclic terpene-like products from R-(+)-sclareolide. | 2003-08-22 |
|
| Identification of regulatory sequence elements within the transcription promoter region of NpABC1, a gene encoding a plant ABC transporter induced by diterpenes. | 2003-07 |
|
| A study on the synthesis of antiangiogenic (+)-coronarin A and congeners from (+)-sclareolide. | 2003-06-16 |
|
| Enantiospecific synthesis of the antituberculosis marine sponge metabolite (+)-puupehenone. The arenol oxidative activation route. | 2002-10-31 |
|
| The ABC transporter SpTUR2 confers resistance to the antifungal diterpene sclareol. | 2002-06 |
|
| An approach to furolabdanes and their photooxidation derivatives from R-(+)-sclareolide. | 2002-05 |
|
| Total synthesis and determination of the absolute configuration of coscinosulfate. A new selective inhibitor of Cdc25 protein phosphatase. | 2001-11-02 |
|
| A plant plasma membrane ATP binding cassette-type transporter is involved in antifungal terpenoid secretion. | 2001-05 |
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/17416571
Curator's Comment: Sclareolide demonstrated a good antibacterial activity against Staphylococcus aureus ATCC 25923, Pseudomonas aeruginosa ATCC 27950, Escherichia coli ATCC 25922 and Enterococcus faecalis ATCC 29212.
Unknown
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
DSLD |
3501 (Number of products:2)
Created by
admin on Mon Mar 31 18:43:48 GMT 2025 , Edited by admin on Mon Mar 31 18:43:48 GMT 2025
|
||
|
JECFA EVALUATION |
SCLAREOLIDE
Created by
admin on Mon Mar 31 18:43:48 GMT 2025 , Edited by admin on Mon Mar 31 18:43:48 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
1156
Created by
admin on Mon Mar 31 18:43:48 GMT 2025 , Edited by admin on Mon Mar 31 18:43:48 GMT 2025
|
PRIMARY | |||
|
37W4O0O6E6
Created by
admin on Mon Mar 31 18:43:48 GMT 2025 , Edited by admin on Mon Mar 31 18:43:48 GMT 2025
|
PRIMARY | |||
|
C109395
Created by
admin on Mon Mar 31 18:43:48 GMT 2025 , Edited by admin on Mon Mar 31 18:43:48 GMT 2025
|
PRIMARY | |||
|
SCLAREOLIDE
Created by
admin on Mon Mar 31 18:43:48 GMT 2025 , Edited by admin on Mon Mar 31 18:43:48 GMT 2025
|
PRIMARY | |||
|
1426934
Created by
admin on Mon Mar 31 18:43:48 GMT 2025 , Edited by admin on Mon Mar 31 18:43:48 GMT 2025
|
PRIMARY | RxNorm | ||
|
209-269-0
Created by
admin on Mon Mar 31 18:43:48 GMT 2025 , Edited by admin on Mon Mar 31 18:43:48 GMT 2025
|
PRIMARY | |||
|
DTXSID8047686
Created by
admin on Mon Mar 31 18:43:48 GMT 2025 , Edited by admin on Mon Mar 31 18:43:48 GMT 2025
|
PRIMARY | |||
|
37W4O0O6E6
Created by
admin on Mon Mar 31 18:43:48 GMT 2025 , Edited by admin on Mon Mar 31 18:43:48 GMT 2025
|
PRIMARY | |||
|
564-20-5
Created by
admin on Mon Mar 31 18:43:48 GMT 2025 , Edited by admin on Mon Mar 31 18:43:48 GMT 2025
|
PRIMARY | |||
|
929262
Created by
admin on Mon Mar 31 18:43:48 GMT 2025 , Edited by admin on Mon Mar 31 18:43:48 GMT 2025
|
PRIMARY |
SUBSTANCE RECORD